AI-designed drug reduces fentanyl consumption in animal models by targeting serotonin receptors

AI-designed drug reduces fentanyl consumption in animal models by targeting serotonin receptors

A recent study published in the Proceedings of the National Academy of Sciences suggests that a novel drug developed using artificial intelligence can significantly reduce fentanyl consumption in animal models. The experimental medication targets specific serotonin receptors in the brain to restore neural pathways altered by addiction. These findings provide evidence that this new compound could eventually offer a non-addictive treatment option …